Backed by Leading Health Systems, Vale Health Launches at Vive 2024; Wellness Marketplace Platform Enables Self-Directed Access to Vetted Products

Creative Proteomics Expands Its Epigenetics Portfolio with Advanced Histone PTMs Analysis Service

Creative Proteomics Unveils Comprehensive Exosome Lipidomics Services

Alfa Chemistry Expands Selection of Click Chemistry Reagents: DBCO, BCN, and Tetrazines Included

Creative Proteomics Enhances Research Capabilities with Urine Untargeted Metabolomics

Matexcel Enlarged Its Offerings for Pure Metal Powders for Research Use

Creative BioMart Launches Protein-Lipids-Nucleic Acid Interaction Assay and Screening Services

25m Health Partners with Clearwater to Develop a Scalable Cybersecurity and Compliance Program Across its Portfolio

Profacgen Launches Fluorescence Polarization Assay for Advanced Protein Interaction Analysis

BioIVT Announces Expansive Fresh Leukopak Capability in Europe

Nominations Open for DrFirst’s 2024 Healthiverse Heroes Award

Nominations Open for DrFirst’s 2024 Healthiverse Heroes Award

Sunbird Bio to Present Positive Data from APEX Alzheimer’s Disease Diagnostic Platform at AD/PD™ 2024

Sunbird Bio announced that new data from a study evaluating its APEX diagnostic platform in Alzheimer’s disease will be presented at the upcoming AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Disease, taking place March 5-9, 2024.

Huateng Pharma Introduces Semaglutide Side Chain

Huateng Pharma offer Semaglutide Side Chain AEEA-AEEA (CAS NO.: 1143516-05-5), SNAC (CAS NO.: 203787-91-1), tBuO-Ste-Glu(AEEA-AEEA)-OtBu (CAS NO.:1118767-16-0), and Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH (CAS NO.: 1662688-20-1).

Lancet Digital Health Publishes Study Confirming MAGENTIQ-COLO™ AI-aided Colonoscopy Technology Improves Adenoma Detection Rates

Lancet Digital Health Publishes Study Confirming MAGENTIQ-COLO™ AI-aided Colonoscopy Technology Improves Adenoma Detection Rates

Cresset® Announces Global Collaboration with Enamine on New Virtual Screening Drug Discovery Technology

Drug discovery specialists Cresset have signed an international collaboration agreement with top global chemical building block providers Enamine to develop new drug discovery technology that can help identify viable drug candidates and unlock future treatment options.

TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada

TriLink’s CleanCap® Capping Technology is Patented Globally & TriLink is the Sole Authorized Manufacturer of CleanCap® Capping Analogs

Biotium Expands Selection of Novel Nuclear Stains for Enhanced Multiplexing Flexibility for Microscopy and Flow Cytometry Applications

Biotium has announced the expansion of its NucSpot® Nuclear Stains lineup, offering unprecedented specificity and flexibility for nuclear counterstaining.

Healthcare 2.0: How Precision Medicine Sector is Reshaping the Future

AES Clean Technology appoints new Vice President of Engineering

AES Clean Technology appoints new Vice President of Engineering  Montgomeryville, Pennsylvania, February 20th, 2024: AES Clean Technology, a leading provider of high-performance modular cleanroom facilities, has appointed Chris Barbieri as Vice President of Engineering. With over 20 years of experience in the life science industry and deep expertise in engineering and project delivery, Chris will oversee all aspects of engineering operations, including product development, innovation, and technological advancement initiatives that are aligned with AES’ strategic vision. In addition, he will focus on streamlining the team’s processes, driving consistency, and fostering a culture of technical excellence and innovation.

Horizon CME Announces First Annual Summit for Novel Therapeutics in Oncology & Precision Medicine in Cancer (STOP Cancer)

Horizon CME has announced its sponsorship of the first annual summit for the multidisciplinary conference, Novel Therapeutics in Oncology & Precision Medicine in Cancer (STOP Cancer).